| Title: | Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? |
| Journal: | Pancreas |
| Published: | 1 Oct 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37078934/ |
| DOI: | https://doi.org/10.1097/mpa.0000000000002145 |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119745 |
| Citations: | 2 (2 in last 2 years) as of 8 Aug 2024 |
Publication 8142
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
OBJECTIVES: To analyze whether use of proton pump inhibitors increase the risk for pancreatic cancer in a mouse model and human clinical cohorts.</p>
METHODS: p48-Cre/LSL-KrasG12D mice that develop precancerous pancreatic intraepithelial neoplasia (PanINs) were treated with low- or high-dose proton pump inhibitors (PPIs) orally for 1 and 4 months. The mechanism for the cholecystokinin receptor 2 (CCK-2R) activation was investigated in vitro. Two resources were employed to analyze the risk of pancreatic cancer in human subjects with PPI use.</p>
RESULTS: Serum gastrin levels were increased 8-fold (P < 0.0001) in mice treated with chronic high-dose PPIs, and this change correlated with an increase (P = 0.02) in PanIN grade and the development of microinvasive cancer. The CCK-2R expression was regulated by microRNA-148a in the p48-Cre/LSL-KrasG12D mice pancreas and in human pancreatic cancer cells in vitro. Proton pump inhibitor consumption in human subjects was correlated with pancreatic cancer risk (odds ratio, 1.54). A validation analysis conducted using the large-scale United Kingdom Biobank database confirmed the correlation (odds ratio, 1.9; P = 0.00761) of pancreatic cancer risk with PPI exposure.</p>
CONCLUSIONS: This investigation revealed in both murine models and human subjects, PPI use is correlated with a risk for development of pancreatic cancer.</p>
12 Authors
- Matthew A. Huber
- Sandeep Nadella
- Hong Cao
- Bhaskar Kallakury
- Robin D. Tucker
- Martha D. Gay
- Narayan Shivapurkar
- Elijah F. Edmondson
- Yuanzhen Yue
- Wenyu Dou
- Hong-Bin Fang
- Jill P. Smith
Enabling scientific discoveries that improve human health